| MEDLINE /PubMed |
#1 (pre-exposure prophylaxis OR “PrEP” OR “Pre Exposure Prophylaxis” OR “Pre-Exposure Prophylaxi” OR “Prophylaxis, Pre-Exposure” OR “Pre-Exposure Prophylaxis (PrEP)” OR “Pre Exposure Prophylaxis (PrEP)” OR “Pre-Exposure Prophylaxi (PrEP)” OR “Anti-HIV Agents” OR “Agents, Anti-HIV” OR “Anti HIV Agents” OR “Anti-AIDS Agents” OR “Agents, Anti-AIDS” OR “Anti AIDS Agents” OR “Anti-HIV Drugs” OR “Anti HIV Drugs” OR “Drugs, Anti-HIV” OR “AIDS Drugs” OR “Drugs, AIDS” OR “Anti-AIDS Drugs” OR “Anti AIDS Drugs”) |
| #2 (HIV Infection [MeSH] OR HIV [MeSH] OR “Human Immunodeficiency Virus” OR “Immunodeficiency Virus, Human” OR “Immunodeficiency Viruses, Human” OR “Virus, Human Immunodeficiency” OR “Viruses, Human Immunodeficiency” OR “Human Immunodeficiency Viruses” OR “Human T Cell Lymphotropic Virus Type III” OR “Human T-Cell Lymphotropic Virus Type III” OR “Human T-Cell Leukemia Virus Type III” OR “AIDS Virus” OR “AIDS Viruses” OR “Virus, AIDS” OR “Viruses, AIDS”) |
| #3 (medication adherence [MeSH] OR treatment adherence and compliance [MeSH] OR “Drug Adherence” OR “Adherence, Drug” OR “Medication Nonadherence” OR “Nonadherence, Medication” OR “Medication Noncompliance” OR “Noncompliance, Medication” OR “Medication Non-Adherence” OR “Medication Non Adherence” OR “Non-Adherence, Medication” OR “Medication Persistence” OR “Persistence, Medication” OR “Medication Compliance” OR “Compliance, Medication” OR “Medication Non-Compliance” OR “Medication Non Compliance” OR “Non-Compliance, Medication” OR “Drug Compliance” OR “Compliance, Drug” OR “Therapeutic Adherence and Compliance” OR “Treatment Adherence” OR “Adherence, Treatment” OR “Therapeutic Adherence” OR “Adherence, Therapeutic”) |
| #4 (health services accessibility [MeSH] OR “Health Services Availability” OR “Accessibility of Health Services” OR “Accessibility, Health Services” OR “Access to Health Services” OR “Access to Health Care” OR “Access to Therapy” OR “Access to Therapies” OR “Therapy, Access to” OR “Access to Treatment” OR “Access to Treatments” OR “Treatment, Access to” OR “Health Services Geographic Accessibility” OR “Program Accessibility” OR “Accessibility, Program” OR “Access To Medicines” OR “Access To Medicine” OR “Access to Medications” OR “Access to Medication” OR “Medication, Access to” OR “Medication Access” OR “Access, Medication”)) |
| #1 AND #2 AND #3 AND #4 |
| CINAHL |
(pre-exposure prophylaxis or prep or preexposure prophylaxis) OR HIV pre exposure prophylaxis AND (healthcare or health care or hospital or health services or health facilities) AND (barriers or obstacles or challenges) AND (patient compliance or patient adherence) |
| Academic Search Premier |
(pre-exposure prophylaxis or prep or preexposure prophylaxis) OR hiv pre exposure prophylaxis AND ( healthcare or health care or hospital or health services or health facilities ) AND ( barriers or obstacles or challenges ) AND ( patient compliance or patient adherence ) |
| SCOPUS |
(TITLE-ABS-KEY(“pre-exposure prophylaxis”) AND TITLE-ABS-KEY (“HIV”) AND TITLE-ABS-KEY (“Health Services Accessibility”) OR TITLE-ABS-KEY (“medication adherence”) OR TITLE-ABS-KEY (“treatment compliance”)) AND (LIMIT-TO(PUBYEAR, 2021) OR LIMIT-TO PUBYEAR, 2020) OR LIMIT-TO (PUBYEAR, 2019) OR LIMIT-TO (PUBYEAR, 2018) OR LIMIT-TO (PUBYEAR, 2017) OR LIMIT-TO (PUBYEAR, 2016) OR LIMIT-TO (PUBYEAR, 2015) OR LIMIT-TO (PUBYEAR, 2014) OR LIMIT-TO (PUBYEAR, 2013) OR LIMIT-TO (PUBYEAR, 2012) OR LIMIT-TO (PUBYEAR, 2011)) AND ( LIMIT-TO(DOCTYPE, “ar”)) |
